Document Type : Original Article
Authors
- Vahid Mohammadkarimi 1
- Pariya Kouhi 2
- Noushafarin Baziar 3
- Javad Kojuri 4
- Nazanin Hosseini 5
- Reza Golchin Vafa 5
- Mohammad Montaseri 5
- Ebrahim Moghimi Sarani 6
1 Hematology Research Center, Shiraz University of Medical Science, Shiraz, Iran
2 Department of Internal Medicine, Shiraz University of Medical Science, Shiraz, Iran
3 Student Research Committee, Shiraz University of Medical Science, Shiraz, Iran
4 Department of Cardiology, Faculty of Medicine, Shiraz University of Medical Science, Shiraz, Iran
5 Professor Kojuri Cardiology Clinic, Niayesh Medical Complex, Shiraz, Iran
6 Research Center for Psychiatry and Behavioral Science, Shiraz University of Medical Science, Shiraz, Iran
Abstract
Introduction: Both benzodiazepines and cardiovascular disease independently increase dementia risk, while anxiety and other psychiatric disorders may exacerbate cardiovascular diseases. Abrupt discontinuation of benzodiazepines can lead to serious complications, making assessment of benzodiazepine use and psychiatric comorbidities particularly important in this patient population.
Methods: This cross-sectional study was conducted in 2018, among cardiovascular patients referred to the Cardiovascular Ward of Imam Reza Clinic (Shiraz, Iran). Using the cluster sampling method, we collected data on cardiovascular disease type, potential psychiatric comorbidities, and benzodiazepine use patterns.
Results: The study included 513 participants aged 18-80 years (265 men, 51.7%). Ischemic heart disease was the most prevalent cardiovascular condition (n=405, 78.9%). Psychiatric disorders were present in 13.25% (n=68) of participants, with alprazolam being the most commonly used benzodiazepine. No significant correlations were found between benzodiazepine use and psychiatric disorders (P=0.814), cigarette smoking (P=0.892), or opioid use (P=0.347).
Conclusion: The findings demonstrated a significant prevalence of both benzodiazepine use and psychiatric disorders (particularly anxiety and depression) among cardiovascular patients, often without appropriate pharmacological treatment. These results underscored the importance of routine screening for psychiatric comorbidities and benzodiazepine use in all cardiovascular patients, regardless of age or sex.
Keywords
- Nielsen S. Benzodiazepines. Curr Top Behav Neurosci. 2017;34:141-59.
- Griffin CE, 3rd, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013;13(2):214-23.
- Votaw VR, Geyer R, Rieselbach MM, McHugh RK. The epidemiology of benzodiazepine misuse: A systematic review. Drug Alcohol Depend. 2019;200:95-114.
- Maust DT, Lin LA, Blow FC. Benzodiazepine Use and Misuse Among Adults in the United States. Psychiatr Serv. 2019;70(2):97-106.
- Gundugurti PR, Bhattacharyya R, Koneru A. Management of Psychiatric Disorders in Patients with Cardiovascular Diseases. Indian J Psychiatry. 2022;64(Suppl 2):S355-S65.
- Picton JD, Marino AB, Nealy KL. Benzodiazepine use and cognitive decline in the elderly. Am J Health Syst Pharm. 2018;75(1):e6-e12.
- Islam MM, Iqbal U, Walther B, Atique S, Dubey NK, Nguyen PA, et al. Benzodiazepine Use and Risk of Dementia in the Elderly Population: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2016;47(3-4):181-91.
- Seldenrijk A, Vogelzangs N, Batelaan NM, Wieman I, van Schaik DJ, Penninx BJ. Depression, anxiety and 6-year risk of cardiovascular disease. J Psychosom Res. 2015;78(2):123-9.
- Balon R, Rafanelli C, Sonino N. Benzodiazepines: A Valuable Tool in the Management of Cardiovascular Conditions. Psychother Psychosom. 2018;87(6):327-30.
- Mesrine S, Gusto G, Clavel-Chapelon F, Boutron-Ruault MC, Fournier A. Use of benzodiazepines and cardiovascular mortality in a cohort of women aged over 50 years. Eur J Clin Pharmacol. 2018;74(11):1475-84.
- Liu S, Soedamah-Muthu SS, van Meerten SC, Kromhout D, Geleijnse JM, Giltay EJ. Use of benzodiazepine and Z-drugs and mortality in older adults after myocardial infarction. Int J Geriatr Psychiatry. 2023;38(1):e5861.
- Surinkaew S, Chattipakorn S, Chattipakorn N. Roles of mitochondrial benzodiazepine receptor in the heart. Can J Cardiol. 2011;27(2):262 e3 -13.
- Wu CS, Ting TT, Wang SC, Chang IS, Lin KM. Effect of benzodiazepine discontinuation on dementia risk. Am J Geriatr Psychiatry. 2011;19(2):151-9.
- Billioti de Gage S, Pariente A, Begaud B. Is there really a link between benzodiazepine use and the risk of dementia? Expert Opin Drug Saf. 2015;14(5):733-47.
- Penninkilampi R, Eslick GD. A Systematic Review and Meta-Analysis of the Risk of Dementia Associated with Benzodiazepine Use, After Controlling for Protopathic Bias. CNS Drugs. 2018;32(6):485-97.
- Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry. 2005;66 Suppl 2:9-13.
- Blanco C, Han B, Jones CM, Johnson K, Compton WM. Prevalence and Correlates of Benzodiazepine Use, Misuse, and Use Disorders Among Adults in the United States. J Clin Psychiatry. 2018;79(6).
- Ma TT, Wang Z, Qin X, Ju C, Lau WCY, Man KKC, et al. Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008 to 2018: a sales data analysis. Sleep. 2023;46(10).
- Agarwal SD, Landon BE. Patterns in Outpatient Benzodiazepine Prescribing in the United States. JAMA Netw Open. 2019;2(1):e187399.
- Zhang Y, Zhou XH, Meranus DH, Wang L, Kukull WA. Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition. Alzheimer Dis Assoc Disord. 2016;30(2):113-7.
- Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, et al. Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiatry. 2016;73(1):39-47.
- Maust DT, Lin LA, Blow FC. Benzodiazepine Use and Misuse Among Adults in the United States. Psychiatr Serv. 2019;70(2):97-106.
- Madruga CS, Paim TL, Palhares HN, Miguel AC, Massaro LTS, Caetano R, et al. Prevalence of and pathways to benzodiazepine use in Brazil: the role of depression, sleep, and sedentary lifestyle. Braz J Psychiatry. 2019;41(1):44-50.
- Thylstrup B, Clausen T, Hesse M. Cardiovascular disease among people with drug use disorders. Int J Public Health. 2015;60(6):659-68.
- Saeidinejat S, Movaffagh J, Setayesh Y. Pattern of benzodiazepine use in outpatients in mashad, Iran. Iranian Journal of Epidemiology. 2011;7(2):60-6.
- Assari S, Moghani Lankarani M, Dejman M, Farnia M, Alasvand R, Sehat M, et al. Drug Use among Iranian Drivers Involved in Fatal Car Accidents. Front Psychiatry. 2014;5:69.
- Babakhanian M, Sadeghi M, Mansoori N, Alam Mehrjerdi Z, Tabatabai M. Nonmedical abuse of benzodiazepines in opiate-dependent patients in tehran, iran. Iran J Psychiatry Behav Sci. 2012;6(1):62-7.
- Heun R, Potluri R. The burden of cardiovascular disease amongst psychiatric patients. International Journal of Cardiology. 2013;169:e65-e6.
- Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163-80.
- Febrianto Y, Tanzil S, Parulian T. The Prevalence of Alprazolam Uses in Geriatric Patients at Dr. Mohammad Hoesin Hospital Palembang. International Journal of Public Health Science. 2016;5(2):193-200.
- Lee J, Salloum RG, Lindstrom K, Kathryn McHugh R. Benzodiazepine misuse and cigarette smoking status in US adults: Results from the National Survey on Drug Use and Health, 2015-2018. Addict Behav. 2021;123:107058.
- Ostroumov A, Wittenberg RE, Kimmey BA, Taormina MB, Holden WM, McHugh AT, et al. Acute Nicotine Exposure Alters Ventral Tegmental Area Inhibitory Transmission and Promotes Diazepam Consumption. eNeuro. 2020;7(2).
)